Literature DB >> 6411832

Posttransfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents.

D W Bradley, J E Maynard, H Popper, E H Cook, J W Ebert, K A McCaustland, C A Schable, H A Fields.   

Abstract

Two separate and distinct episodes of non-A, non-B hepatitis were induced in each of two chimpanzees by two inocula: one containing a chloroform-resistant agent and the other containing a chloroform-sensitive agent. Both agents were recovered from liver tissue and plasma obtained from a single chimpanzee during the acute and chronic phases of infection with a factor VIII concentrate, respectively. The chloroform-resistant agent did not cause unique changes in hepatocytes; in contrast, the chloroform-sensitive agent did induce the formation of cytoplasmic tubules, convoluted endoplasmic reticulum, and dense reticular inclusion bodies. The latter changes are similar in character to those induced in infected cells by some enveloped mammalian RNA viruses.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411832      PMCID: PMC7109850          DOI: 10.1093/infdis/148.2.254

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

1.  A diagnostic approach to different types of non-A non-B acute hepatitis through the evaluation of the lobular distribution of hepatocytic damage.

Authors:  S Takase; A Takada; H Sato
Journal:  Gastroenterol Jpn       Date:  1990-02

Review 2.  Hepatology.

Authors:  P M Harrison; J Y Lau; R Williams
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

Review 3.  Viral hepatitis.

Authors:  J Y Lau; G J Alexander; A Alberti
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 4.  Hepatitis C virus and transfusion transmitted liver disease: review.

Authors:  J C Underwood
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

5.  Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden.

Authors:  L Mattsson; L Grillner; M von Sydow; S Bergdahl; O Weiland
Journal:  Infection       Date:  1991 Sep-Oct       Impact factor: 3.553

6.  Early events in hepatitis C virus infection of chimpanzees.

Authors:  Y K Shimizu; A J Weiner; J Rosenblatt; D C Wong; M Shapiro; T Popkin; M Houghton; H J Alter; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

7.  Correlation of serum antibody titers against hepatitis C virus core protein with clinical features by western blot (immunoblot) analysis using a recombinant vaccinia virus expression system.

Authors:  A Nishizono; M Hiraga; K Mifune; H Terao; T Fujioka; M Nasu; T Goto; J Misumi; M Moriyama; Y Arakawa
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

8.  Structure and organization of the hepatitis C virus genome isolated from human carriers.

Authors:  A Takamizawa; C Mori; I Fuke; S Manabe; S Murakami; J Fujita; E Onishi; T Andoh; I Yoshida; H Okayama
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

Review 9.  Viral markers in the treatment of hepatitis B and C.

Authors:  H Schmilovitz-Weiss; M Levy; N Thompson; G Dusheiko
Journal:  Gut       Date:  1993       Impact factor: 23.059

10.  Association of hepatitis C virus in human sera with beta-lipoprotein.

Authors:  R Thomssen; S Bonk; C Propfe; K H Heermann; H G Köchel; A Uy
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.